5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY...

por Manganas, K.M., Kotsiafti, K.A., Xydaki, X.A., Patsourakos, D.P., Aggeli, K.A., Savvidis, S.C., Koskinas, K.I., Delicou, S.D.
Publicado 2023